Pharma

Your Article Summary

See Latest Articles

Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
Onyx Pharmaceuticals, 05/21/09

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. announced that the Ministry of Health, Labour and Welfare in Japan has approved Nexavar tablets for the treatment of patients with unresectable hepatocellular carcinoma, a type of liver cancer that accounts for 95 percent of all liver cancer cases in Japan1. Nexavar is also currently available in Japan as an approved treatment for unresectable or metastatic renal cell carcinoma.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Telmisartan/amlodipine: approved for high blood pressure
Formulary , 12/16/09

Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

 See all of Drug/Product Approvals